表紙
市場調查報告書

全球血液市場:預測(2019-2028)

Global Blood Market Forecast 2019-2028

出版商 Inkwood Research 商品編碼 952506
出版日期 內容資訊 英文 189 Pages
商品交期: 2-3個工作天內
價格
全球血液市場:預測(2019-2028) Global Blood Market Forecast 2019-2028
出版日期: 2020年08月03日內容資訊: 英文 189 Pages
簡介

據估計,2019-2028年全球血液市場將以4.16%的複合年增長率增長。市場增長的主要驅動力是全球對血液和血液相關產品的需求,人口老齡化,血液和血漿捐贈的增加,輸血和血液篩查設備以及血液的發展例如,制定有關篩查的政府法規。尤其是在亞太地區,隨著慢性病和醫院獲得性感染患者的增多,以採血設備為中心的巨大市場機會正在湧現。

在本報告中,我們分析了全球血液市場-各種血液測試,治療和治療市場-並分析了市場的基本結構,主要驅動因素和限制因素以及過去3年的市場規模前景9年),按產品/最終用戶和地區劃分的詳細趨勢,市場競爭趨勢,主要公司的概況(公司概況,主要產品/服務,業務策略等)。

第1章調查範圍和方法

第2章執行摘要

第3章市場動態

  • 母市場分析:軟件市場
  • 市場定義
  • 主要市場驅動力
    • 全球對血液和其他血液相關產品的需求不斷增長
    • 全球老年人口激增
    • 增加血液和血漿捐贈
    • 政府對血液測試的承諾
    • 輸血和血液篩查設備的進步
  • 主要市場限制因素
    • 先進採血設備的高成本
    • 熟練的實驗室專家的深度

第4章主要分析

  • 主要投資考慮
  • 波特的五力分析
  • 市場機會矩陣
  • 供應商狀況
  • 新型冠狀病毒感染(COVID-19)的影響-血液市場

第5章按產品劃分的市場

  • 全血採集
    • 全血採集裝置
    • 全血採集試劑
  • 原料血漿收集
    • 原料血漿收集裝置
    • 原料血漿收集試劑
  • 血液治療
    • 靜脈內免疫球蛋白(IVIG)
    • 白蛋白
    • 超免疫
    • 因子VIII
    • IX因子
    • 其他血液治療
  • 血型測定
    • 輸血裝置
    • 血型試劑
  • 血液篩查
    • 血液檢查裝置
    • 血液檢查試劑
  • 血液處理
    • 血液處理裝置
    • 血液處理試劑

第6章最終用戶的市場

  • 血液銀行/血液成分銀行
  • 診斷實驗室
  • 門診手術中心
  • 醫院
  • 其他最終用戶

第7章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 俄羅斯
    • 比利時
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 印度尼西亞
    • 泰國
    • 越南
    • 澳大利亞/新西蘭
    • 其他亞太國家
  • 其他國家(行)
    • 拉丁美洲
    • 中東/非洲

第8章公司簡介

  • ABBOTT LABORATORIES
  • BIO-RAD LABORATORIES INC
  • CSL LIMITED (CSL BEHRING)
  • F HOFFMANN-LA ROCHE LTD
  • GRIFOLS INTERNATIONAL SA
  • HAEMONETICS CORPORATION
  • MERCK & CO INC
  • NOVO NORDISK A/S
  • BAXTER INTERNATIONAL INC
  • BECTON DICKINSON AND COMPANY
  • FRESENIUS KABI AG
  • ORTHO CLINICAL DIAGNOSTICS
  • Ъюх (TERUMO BCT INC)
  • IMMUCOR INC
目錄
Product Code: 32924

KEY FINDINGS

The global blood market is estimated to grow with a CAGR of 4.16% across the forecast years of 2019 to 2028. Primary factors attributed to driving the market growth include, the increase in the worldwide demand for blood and blood-related products, the growing geriatric population, rise in blood and plasma donations, developments in blood transfusion and screening instruments, and the introduction of government regulations for blood screening.

MARKET INSIGHTS

The global blood market entails the sale of whole blood as well as blood components using diverse mediums like, hospitals, and blood banks, among others. Blood transfusion is typically performed in medical facilities during disease treatments and surgeries, and involves the red blood cells' transfer from one person to another. The donor's blood is collected and then categorized in terms of requirements and components. Since the transfusion process only requires blood components, an entire unit of blood is seldom used.

In recent years, there has been a rapid increase in the geriatric population across the world. Consequently, they are more susceptible to numerous chronic conditions like cardiovascular diseases, type 2 diabetes, arthritis, and obesity. The elderly are also prone to distinct types of cancers like prostate and stomach cancer. Thus, the predisposition to various medical complications, leads to the need for blood and source plasma treatments. As a result, the rise in geriatric populace is expected to raise the demand for blood and plasma collecting reagents and instruments and bolster the market growth.

REGIONAL INSIGHTS

The geographical analysis of the global blood market growth includes the Asia Pacific, North America, Europe, and the rest of the world. Developing economies in the Asia Pacific blood market is witnessing an increasing number of patients suffering from chronic ailments and developments within healthcare institutions. As a result, the region offers profitable opportunities for key market players, especially in the blood collection equipment division.

COMPETITIVE ANALYSIS

The industrial rivalry within the global blood market is estimated to be high across the forecast period. The intense competition is attributed to the rise in healthcare expenses, and the increased prevalence of chronic diseases that require a blood transfusion. Some of the renowned companies in the market include, Bio-Rad Laboratories Inc, Immucor Inc, Abbott Laboratories, CSL Limited, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
    • 3.2.2. SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
    • 3.2.3. RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
    • 3.2.4. PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
    • 3.2.5. PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
    • 3.3.2. DEARTH OF SKILLED LABORATORY PROFESSIONALS

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. IMPACT OF COVID - BLOOD MARKET

5. MARKET BY PRODUCT

  • 5.1. WHOLE BLOOD COLLECTION
    • 5.1.1. WHOLE BLOOD COLLECTION SYSTEMS
    • 5.1.2. WHOLE BLOOD COLLECTION REAGENTS
  • 5.2. SOURCE PLASMA COLLECTION
    • 5.2.1. SOURCE PLASMA COLLECTION SYSTEMS
    • 5.2.2. SOURCE PLASMA COLLECTION REAGENTS
  • 5.3. BLOOD THERAPEUTICS
    • 5.3.1. INTRAVENOUS IMMUNOGLOBULIN (IVIG)
    • 5.3.2. ALBUMIN
    • 5.3.3. HYPERIMMUNE
    • 5.3.4. FACTOR VIII
    • 5.3.5. FACTOR IX
    • 5.3.6. OTHER BLOOD THERAPEUTICS
  • 5.4. BLOOD TYPING
    • 5.4.1. BLOOD TYPING SYSTEMS
    • 5.4.2. BLOOD TYPING REAGENTS
  • 5.5. BLOOD SCREENING
    • 5.5.1. BLOOD SCREENING SYSTEMS
    • 5.5.2. BLOOD SCREENING REAGENTS
  • 5.6. BLOOD PROCESSING EQUIPMENT
    • 5.6.1. BLOOD PROCESSING EQUIPMENT SYSTEMS
    • 5.6.2. BLOOD PROCESSING EQUIPMENT REAGENTS

6. MARKET BY END-USER

  • 6.1. BLOOD & BLOOD COMPONENT BANKS
  • 6.2. DIAGNOSTIC LABORATORIES
  • 6.3. AMBULATORY SURGICAL CENTERS
  • 6.4. HOSPITALS
  • 6.5. OTHER END-USERS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. GERMANY
    • 7.2.3. FRANCE
    • 7.2.4. ITALY
    • 7.2.5. RUSSIA
    • 7.2.6. BELGIUM
    • 7.2.7. POLAND
    • 7.2.8. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. JAPAN
    • 7.3.3. INDIA
    • 7.3.4. SOUTH KOREA
    • 7.3.5. INDONESIA
    • 7.3.6. THAILAND
    • 7.3.7. VIETNAM
    • 7.3.8. AUSTRALIA & NEW ZEALAND
    • 7.3.9. REST OF ASIA PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. BIO-RAD LABORATORIES INC
  • 8.3. CSL LIMITED (CSL BEHRING)
  • 8.4. F HOFFMANN-LA ROCHE LTD
  • 8.5. GRIFOLS INTERNATIONAL SA
  • 8.6. HAEMONETICS CORPORATION
  • 8.7. MERCK & CO INC
  • 8.8. NOVO NORDISK A/S
  • 8.9. BAXTER INTERNATIONAL INC
  • 8.10. BECTON DICKINSON AND COMPANY
  • 8.11. FRESENIUS KABI AG
  • 8.12. ORTHO CLINICAL DIAGNOSTICS
  • 8.13. TERUMO CORPORATION (TERUMO BCT INC)
  • 8.14. IMMUCOR INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BLOOD
  • TABLE 2: GLOBAL BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ALBUMIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL ALBUMIN SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL HYPERIMMUNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL HYPERIMMUNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL FACTOR VIII MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL FACTOR VIII MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL FACTOR IX MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL FACTOR IX MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL BLOOD TYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL BLOOD TYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLI

ON)

  • TABLE 32: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL BLOOD SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL BLOOD SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL BLOOD MARKET, BY END-USERS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL BLOOD MARKET, BY END-USERS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL BLOOD MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: GLOBAL BLOOD MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 62: NORTH AMERICA BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: NORTH AMERICA BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 64: EUROPE BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 65: EUROPE BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 66: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 67: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 68: REST OF WORLD BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 69: REST OF WORLD BLOOD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY WHOLE BLOOD COLLECTION, IN 2019
  • FIGURE 8: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY SOURCE PLASMA COLLECTION, IN 2019
  • FIGURE 12: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL BLOOD MARKET, BY BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD THERAPEUTICS, IN 2019
  • FIGURE 16: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL BLOOD MARKET, BY ALBUMIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL BLOOD MARKET, BY HYPERIMMUNE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL BLOOD MARKET, BY FACTOR VIII, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL BLOOD MARKET, BY FACTOR IX, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL BLOOD MARKET, BY OTHER BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL BLOOD MARKET, BY BLOOD TYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD TYPING, IN 2019
  • FIGURE 24: GLOBAL BLOOD MARKET, BY BLOOD TYPING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL BLOOD MARKET, BY BLOOD TYPING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL BLOOD MARKET, BY BLOOD SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD SCREENING, IN 2019
  • FIGURE 28: GLOBAL BLOOD MARKET, BY BLOOD SCREENING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL BLOOD MARKET, BY BLOOD SCREENING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD PROCESSING EQUIPMENT, IN 2019
  • FIGURE 32: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 35: GLOBAL BLOOD MARKET, BY BLOOD & BLOOD COMPONENT BANKS, 2019-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL BLOOD MARKET, BY DIAGNOSTIC LABORATORIES, 2019-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL BLOOD MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL BLOOD MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL BLOOD MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: NORTH AMERICA BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: UNITED STATES BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: CANADA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: EUROPE BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 44: UNITED KINGDOM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: GERMANY BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: FRANCE BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: ITALY BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: RUSSIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: BELGIUM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: POLAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 51: REST OF EUROPE BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: ASIA PACIFIC BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 53: CHINA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 54: JAPAN BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 55: INDIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 56: SOUTH KOREA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 57: INDONESIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 58: THAILAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 59: VIETNAM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 60: AUSTRALIA & NEW ZEALAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 61: REST OF ASIA PACIFIC BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 62: REST OF WORLD BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 63: LATIN AMERICA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 64: MIDDLE EAST & AFRICA BLOOD MARKET, 2019-2028 (IN $ MILLION)